ERBB2 and neoplasm: In a preclinical study, HER2 BAT-associated activated T cells demonstrate anti-tumor cytotoxicity, effective intratumoral trafficking, and secretion of cytokines such as IFNγ, TNFα, and GM-CSF, upon tumor engagement.